PROPOXYPHENE COMPOUND-65 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propoxyphene Compound-65, and what generic alternatives are available?
Propoxyphene Compound-65 is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in PROPOXYPHENE COMPOUND-65 is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROPOXYPHENE COMPOUND-65?
- What are the global sales for PROPOXYPHENE COMPOUND-65?
- What is Average Wholesale Price for PROPOXYPHENE COMPOUND-65?
Summary for PROPOXYPHENE COMPOUND-65
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 155 |
| DailyMed Link: | PROPOXYPHENE COMPOUND-65 at DailyMed |
US Patents and Regulatory Information for PROPOXYPHENE COMPOUND-65
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | PROPOXYPHENE COMPOUND-65 | aspirin; caffeine; propoxyphene hydrochloride | CAPSULE;ORAL | 083101-002 | Jun 24, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
